Evaluation of the endothelial glycocalyx in premature and mature neonates

Evaluation of the endothelial glycocalyx in premature and mature neonates - GlycoNeo Study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00022031

Enrollment

Registered

2020-06-08

Start date

2013-12-01

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

P07.01 Z38.0

Interventions

Group 1: Mature neoantes Investigation of the cutaneous microcirculation between 36 and 72h of life using Sidestream Darkfield Imaging Group 2: Premature neonates (< 37+0 weeks of gestation) Investig

Eligibility

Sex/Gender

All

Age

No minimum to 3 Days

Inclusion criteria

Inclusion criteria: parental consent

Exclusion criteria

Exclusion criteria: significant congenital malformations suspected syndromal disease dark skin pigmentation (technical limitation)

Design outcomes

Primary

Measure	Time frame
Quantification of endothelial glycocalyx thickness by measurement of the Perfused Boundary Region (PBR)	—

Secondary

Measure	Time frame
Influence of clinical and laboratory parameters on PBR	—

Countries

Germany

Contacts

Public ContactClaudia Nußbaum

Dr. von Haunersches Kinderspital

claudia.nussbaum@med.uni-muenchen.de0049-89-4400-54535

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026